DrugPatentWatch Database Preview
ASENDIN Drug Profile
Email this page to a colleague
» See Plans and PricingWhen do Asendin patents expire, and what generic alternatives are available?
Asendin is a drug marketed by Lederle and is included in one NDA.
The generic ingredient in ASENDIN is amoxapine. There are four drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the amoxapine profile page.
US ANDA Litigation and Generic Entry Outlook for Asendin
A generic version of ASENDIN was approved as amoxapine by WATSON LABS on August 28th, 1992.
Summary for ASENDIN
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Bulk Api Vendors: | 83 |
| Patent Applications: | 4,300 |
| Formulation / Manufacturing: | see details |
| DailyMed Link: | ASENDIN at DailyMed |
US Patents and Regulatory Information for ASENDIN
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Lederle | ASENDIN | amoxapine | TABLET;ORAL | 018021-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | Start Trial | Start Trial | Start Trial | ||||
| Lederle | ASENDIN | amoxapine | TABLET;ORAL | 018021-004 | Approved Prior to Jan 1, 1982 | DISCN | No | No | Start Trial | Start Trial | Start Trial | ||||
| Lederle | ASENDIN | amoxapine | TABLET;ORAL | 018021-002 | Approved Prior to Jan 1, 1982 | DISCN | No | No | Start Trial | Start Trial | Start Trial | ||||
| Lederle | ASENDIN | amoxapine | TABLET;ORAL | 018021-003 | Approved Prior to Jan 1, 1982 | DISCN | No | No | Start Trial | Start Trial | Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for ASENDIN
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
|---|---|---|---|---|---|---|---|
| Lederle | ASENDIN | amoxapine | TABLET;ORAL | 018021-002 | Approved Prior to Jan 1, 1982 | Start Trial | Start Trial |
| Lederle | ASENDIN | amoxapine | TABLET;ORAL | 018021-002 | Approved Prior to Jan 1, 1982 | Start Trial | Start Trial |
| Lederle | ASENDIN | amoxapine | TABLET;ORAL | 018021-001 | Approved Prior to Jan 1, 1982 | Start Trial | Start Trial |
| Lederle | ASENDIN | amoxapine | TABLET;ORAL | 018021-003 | Approved Prior to Jan 1, 1982 | Start Trial | Start Trial |
| Lederle | ASENDIN | amoxapine | TABLET;ORAL | 018021-002 | Approved Prior to Jan 1, 1982 | Start Trial | Start Trial |
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
International Patents for ASENDIN
| Country | Patent Number | Estimated Expiration |
|---|---|---|
| Brazil | 6457122 | Start Trial |
| Sweden | 317382 | Start Trial |
| Switzerland | 517759 | Start Trial |
| Switzerland | 484924 | Start Trial |
| Norway | 123459 | Start Trial |
| >Country | >Patent Number | >Estimated Expiration |
